News Focus
News Focus
Followers 88
Posts 3114
Boards Moderated 0
Alias Born 09/07/2014

Re: Slave1 post# 774904

Wednesday, 07/09/2025 12:19:44 PM

Wednesday, July 09, 2025 12:19:44 PM

Post# of 828281
Slave1, Love your posts! Question: Could the Mill Creek research/libray be one of the in-licencing projects that management talks about in its Quarterlies/Annual reports?
And thank you for the detail in the below paragraph. Also, is Mill Creek a business, hospital, clinic??

Slave wrote:

On Mill Creek, their approach may look different on the surface, using in vitro-expanded tumor cell lines to generate an antigen library, but the downstream process still appears to involve dendritic cells, patient matching, and antigen presentation. So yes, there’s definitely conceptual overlap.

That said, this isn’t unusual. Trials like these, especially in academic settings, are often built on in-licensed platforms or shared technology foundations. In fact, many are intentionally structured to evaluate specific components of an existing system under new conditions or to generate complementary data. So this is not a threat to NWBO’s IP, it’s likely a strategic parallel effort, not a competing one.

Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News